ADRENAL SENSITIVITY TO ANGIOTENSIN-II AND UNDISCOVERED ALDOSTERONE STIMULATING FACTORS IN HYPERTENSION

被引:76
作者
BROWN, RD [1 ]
WISGERHOF, M [1 ]
CARPENTER, PC [1 ]
BROWN, G [1 ]
JIANG, NS [1 ]
KAO, P [1 ]
HEGSTAD, R [1 ]
机构
[1] MAYO CLIN & MAYO FDN, DEPT LAB MED, ROCHESTER, MN 55901 USA
关键词
D O I
10.1016/0022-4731(79)90049-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have determined that the adrenal glands of patients with the syndromes of low-renin essential hypertension and idiopathic hyperaldosteronism are abnormally sensitive to the steroidogenic effect of angiotensin II. The mechanism of this heightened responsiveness to angiotensin II is unknown but may be due to the bilateral adrenal hyperplasia present in many patients with these low-renin hypertension syndromes. We have found that metoclopramide, a dopamine antagonist, causes three-fold increases in levels of plasma aldosterone in normal subjects. These increases could not be accounted for by changes in plasma renin activity, ACTH or potassium. Metoclopramide does not stimulate bovine adrenal glomerulosa cells to produce aldosterone in vitro, suggesting that it stimulates the secretion of aldosterone in vivo indirectly, by increasing the levels or the activity of an undefined aldosterone stimulating factor. We have also found that human urine, after partial purification, stimulates bovine adrenal glomerulosa cells to produce aldosterone in vitro. Urine samples from patients with low-renin essential hypertension or idiopathic hyperaldosteronism have more stimulating activity than urine samples from normal subjects. These preliminary findings support the hypothesis that excessive production of an undefined aldosterone stimulating factor may be the basic abnormality in some cases of idiopathic hyperaldosteronism and low-renin essential hypertension. © 1979.
引用
收藏
页码:1043 / 1050
页数:8
相关论文
共 27 条
[1]  
ALBERT A, 1956, RECENT PROG HORM RES, V12, P227
[2]   TRITIUM LABELING OF LUTEINIZING-HORMONE BY REDUCTIVE METHYLATION [J].
ASCOLI, M ;
PUETT, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 371 (01) :203-210
[3]  
BIGLIERI EG, 1974, CIRC RES, V34, pI183
[4]  
BIGLIERI EG, 1970, CIRC RES, V27, pI195
[5]   ALDOSTERONE METABOLIC-CLEARANCE IS NORMAL IN LOW-RENIN ESSENTIAL HYPERTENSION [J].
BROWN, RD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (04) :661-666
[6]   CONTROL OF PLASMA ALDOSTERONE IN PRIMARY ALDOSTERONISM - DISTINCTION BETWEEN ADENOMA AND HYPERPLASIA [J].
GANGULY, A ;
MELADA, GA ;
LUETSCHER, JA ;
DOWDY, AJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (05) :765-775
[7]   ANOMALOUS POSTURAL RESPONSE OF PLASMA ALDOSTERONE CONCENTRATION IN PATIENTS WITH ALDOSTERONE-PRODUCING ADRENAL ADENOMA [J].
GANGULY, A ;
DOWDY, AJ ;
LUETSCHER, JA ;
MELADA, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 36 (02) :401-404
[8]  
GRIM C, 1974, J CLIN ENDOCR METAB, V39, P247, DOI 10.1210/jcem-39-2-247
[9]   HYPERTENSION, ADRENAL ABNORMALITIES, AND ALTERATIONS IN PLASMA RENIN ACTIVITY [J].
GUNNELLS, JC ;
MCGUFFIN, WL ;
ROBINSON, RR ;
GRIM, CE ;
WELLS, S ;
SILVER, D ;
GLENN, JF .
ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) :901-+
[10]   APPLICATION OF A RADIOIMMUNOASSAY FOR ANGIOTENSIN I TO PHYSIOLOGIC MEASUREMENTS OF PLASMA RENIN ACTIVITY IN NORMAL HUMAN SUBJECTS [J].
HABER, E ;
KOERNER, T ;
PAGE, LB ;
KLIMAN, B ;
PURNODE, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1969, 29 (10) :1349-+